• KU-55933 and Next-Gen ATM Inhibition: Personalized Disease M

  2026-05-19

  Explore the unique role of KU-55933, a potent ATM kinase inhibitor, in advancing DNA damage response research and personalized iPSC-based disease modeling. Gain deep insight into assay design, metabolic endpoints, and translational implications for cancer research.

• Endothelial STING-JAK1 Axis: Tumor Vessel Normalization and

  2026-05-18

  This article reviews recent findings that endothelial STING-JAK1 interactions drive tumor vasculature normalization and enhance antitumor immunity by selectively promoting type I interferon signaling and CD8+ T cell infiltration. The research clarifies cell type–specific mechanisms in cGAS-STING pathway activation and outlines implications for immunotherapy design.

• Oxaliplatin Workflows: Advanced Protocols in Cancer Chemothe

  2026-05-18

  Harness the full potential of Oxaliplatin with evidence-driven workflows that enhance apoptosis induction and overcome chemoresistance in preclinical models. Discover step-by-step protocols, synergistic strategies, and troubleshooting guidance for reliable, translational cancer research.

• 4-Hydroxytamoxifen: Technical Guidance for Lab Research Work

  2026-05-17

  4-Hydroxytamoxifen (SKU B6167) provides researchers with a high-purity, DMSO-soluble estrogen receptor modulator suitable for breast and prostate cancer research, apoptosis assays, and cardiac myocyte studies requiring precise modulation of estrogen receptor activity. It is not compatible with aqueous or ethanol-based protocols and demands strict handling and storage to maintain reagent integrity.

• ATRX Loss Sensitizes High-Grade Glioma Cells to RTK Inhibito

  2026-05-16

  This study reveals that ATRX-deficient high-grade glioma cells display heightened sensitivity to multi-targeted receptor tyrosine kinase (RTK) and PDGFR inhibitors. The findings support integrating ATRX status into the design and interpretation of clinical trials for glioma therapies targeting these pathways.

• WNT5a/GSK3/β-catenin Axis Controls FAP Adipogenesis in Muscl

  2026-05-15

  This study uncovers how the WNT5a/GSK3/β-catenin pathway regulates adipogenesis in skeletal muscle fibro/adipogenic progenitors (FAPs), limiting pathological fat infiltration in muscle tissue. The findings provide mechanistic insight into muscle regeneration and highlight therapeutic targets for myopathies.

• Protein A/G Magnetic Co-IP/IP Kit: Streamlining Protein Comp

  2026-05-15

  The Protein A/G Magnetic Co-IP/IP Kit empowers researchers with rapid, reproducible isolation of protein complexes, supporting high-fidelity protein-protein interaction analysis and antibody purification. Its magnetic bead-based workflow minimizes degradation and enables direct downstream applications such as SDS-PAGE and mass spectrometry.

• Chenodeoxycholic Acid in FXR Signaling: Protocols & Optimiza

  2026-05-14

  Chenodeoxycholic Acid (CDCA) is transforming nuclear receptor signaling studies through robust activation of FXR, enabling precise dissection of cholesterol metabolism and acute kidney injury pathways. This guide details experimental workflows, troubleshooting strategies, and protocol parameters for maximizing CDCA’s impact in metabolic and renal research.

• CD28-ARS2 Axis Drives PKM2 Splicing for CD8+ T Cell Flexibil

  2026-05-14

  This study uncovers how the CD28-ARS2 signaling axis in CD8+ T cells orchestrates alternative splicing of pyruvate kinase (PKM), favoring the PKM2 isoform crucial for metabolic flexibility and antitumor function. The findings reveal a previously unrecognized mechanism linking co-stimulatory signaling to immunometabolic reprogramming, with implications for cancer immunotherapy.

• Influenza Hemagglutinin (HA) Peptide: Precision in Exosome P

  2026-05-13

  Explore the critical role of Influenza Hemagglutinin (HA) Peptide in advanced exosome pathway analysis and protein interaction studies. This article reveals how high-purity HA tag peptide enables precise assay design, connecting new mechanistic insights with robust molecular biology workflows.

• Poly (I:C): Synthetic Double-Stranded RNA Analog for Immune

  2026-05-13

  Poly (I:C), a synthetic double-stranded RNA analog, is the gold standard for robust and reproducible immune activation in antiviral, inflammation, and cell maturation workflows. Leveraging new insights into innate immunity, this guide details protocol optimizations, troubleshooting, and advanced applications for maximizing performance with APExBIO’s Poly(I:C) TLR3 agonist.

• AMPK Regulates Mitophagy-Inflammation Crosstalk in Diabetic

  2026-05-12

  This study demonstrates that AMP-activated protein kinase (AMPK) orchestrates the balance between PINK1/Parkin-mediated mitophagy and NLRP3-driven inflammation in periodontal ligament fibroblasts under mechanical loading, especially in diabetic conditions. The findings highlight a mechanistic link by which AMPK activation can enhance mitochondrial quality control and dampen inflammatory signaling, offering new insight into periodontal disease management in metabolic disorders.

• CP-673451: Redefining Selective PDGFR Inhibition for Transla

  2026-05-12

  This thought-leadership article examines CP-673451, a selective PDGFRα/β inhibitor, offering mechanistic insights and strategic guidance for translational cancer researchers. Drawing on recent breakthroughs in ATRX-deficient glioma models and validated xenograft studies, it contextualizes product performance, workflow optimization, and the next era of angiogenesis-targeted therapeutics.

• Acridine Orange hydrochloride: Practical Guide for DNA/RNA S

  2026-05-11

  Acridine Orange hydrochloride enables precise differential staining of DNA and RNA, supporting robust cell cycle analysis and apoptosis detection in cytochemical workflows. It is best suited for rapid, in situ nucleic acid discrimination via flow cytofluorometry and should not be used in protocols requiring long-term storage of working solutions. Researchers must adhere to recommended solubility and handling guidelines to ensure reproducible results.

• Technical Guide: Angiotensin I/II (1-5) Use in RAS Workflows

  2026-05-11

  Angiotensin I/II (1-5) provides a defined Asp-Arg-Val-Tyr-Ile peptide fragment for modeling blood pressure regulation and aldosterone signaling in renin-angiotensin system (RAS) research. It is intended for cardiovascular and renal physiology workflows; its use outside these boundaries is not supported by product or workflow evidence. Adherence to recommended solubility and storage parameters is critical for experimental reliability.

16676 records 1/1112 page Next 12345 下5页 Last page